Gene · 2317
FLNB: filamin B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FLNB: filamin B. Genes, record 2317. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2317
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O75369 | Filamin-B | 2,602 | 23 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46353 | O75369 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3669 | O75369 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3268 | O75369 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 192 | O75369 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3268 | O75369 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3669 | O75369 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 28497 | O75369 | Espacenet |
| WO 2025032112 A1 | 2025-02-13 | 2 | O75369 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 192 | O75369 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 28497 | O75369 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,659
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FLNB papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| R01AI044115 | Influences of HLA Class I Polymorphisms on immune responses | 13 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| T32CA009476 | Cancer Biology Training Program | 9 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 8 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 7 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 6 | 2025 |
| ZIABC010984 | Adoptive Cell Transfer Immunotherapy of Cancer | 6 | 2025 |
| P01CA018029 | Adult Leukemia Research Center | 5 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 5 | 2025 |
1 to 10 of 2,659Source NIH's project files
See all 2,659 nih grantsPapers3,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Filamin B (FLNB)-Related Spondylocarpotarsal Synostosis Syndrome: Systematic Literature Review and Novel Case Report. | Genes (Basel) | 2026 | 42792948 | PubTator, text mining | PubMed |
| Multi-omics screening and functional validation identify SLC5A6 as a candidate disulfidptosis-related gene and prognostic biomarker in hepatocellular carcinoma. | Front Oncol | 2026 | 42666251 | PubTator, text mining | PubMed |
| HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs. | Biomark Res | 2026 | 42638137 | PubTator, text mining | PubMed |
| Clinical value of serum osteocalcin (N-MID) combined with thyroid transcription factor-1 for predicting bone metastasis of lung cancer. | Am J Cancer Res | 2026 | 42597206 | PubTator, text mining | PubMed |
| LRS1 phosphorylated in response to blue light regulates stomatal opening. | J Plant Res | 2026 | 42573725 | PubTator, text mining | PubMed |
| A placental DNA methylation score associated with early-onset preeclampsia and maternal vascular malperfusion pathology. | Front Epigenet Epigenom | 2026 | 42559650 | PubTator, text mining | PubMed |
| ATP-driven conformational dynamics reveal hidden intermediates in a heterodimeric ABC transporter. | Elife | 2026 | 42535643 | PubTator, text mining | PubMed |
| High-resolution mapping of chromatin conformation in HBeAg-treated macrophage provides insights into pathogenesis of HBV-related liver diseases. | Front Immunol | 2026 | 42534908 | PubTator, text mining | PubMed |
| Genotype-phenotype correlations in children with short stature: results of targeted next-generation sequencing. | J Pediatr Endocrinol Metab | 2026 | 42446396 | PubTator, text mining | PubMed |
Development and Validation of a Six-Gene Signature of Myeloid Antigen Presentation Dysfunction Based on Single-Cell and Multi-Cohort Transcriptomics for Predicting Prognosis and Recurrence of Hepatocellular Carcinoma. | Cancer Inform | 2026 | 42404398 | PubTator, text mining | PubMed |
1 to 10 of 3,759
See all 3,759 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2317
GET https://conductscience.org/api/genes/v1/2317/patents?page=2